Colgate-Palmolive Company (NYSE:CL) Shares Purchased by Mackenzie Financial Corp

Key Points

• Mackenzie Financial Corp increased its holdings in Colgate-Palmolive by 1.5%, amounting to 3,892,865 shares worth approximately $364.8 million as of the latest SEC filing.
• Colgate-Palmolive reported Q1 earnings per share of $0.91, beating expectations by $0.05, despite a 3% decline in quarterly revenue compared to the previous year.
• The company declared a quarterly dividend of $0.52 per share, which will be paid on August 15th, reflecting an annualized dividend yield of 2.37%.

Mackenzie Financial Corp boosted its holdings in Colgate-Palmolive Company (NYSE:CL - Free Report) by 1.5% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 3,892,865 shares of the company's stock after acquiring an additional 56,283 shares during the period. Mackenzie Financial Corp owned 0.48% of Colgate-Palmolive worth $364,761,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently added to or reduced their stakes in the business. Cornerstone Wealth Management LLC boosted its stake in shares of Colgate-Palmolive by 1.2% during the 1st quarter. Cornerstone Wealth Management LLC now owns 9,035 shares of the company's stock worth $847,000 after purchasing an additional 110 shares during the last quarter. Wescott Financial Advisory Group LLC boosted its stake in shares of Colgate-Palmolive by 3.5% during the 4th quarter. Wescott Financial Advisory Group LLC now owns 3,517 shares of the company's stock worth $320,000 after purchasing an additional 119 shares during the last quarter. Aberdeen Wealth Management LLC boosted its stake in shares of Colgate-Palmolive by 0.6% during the 4th quarter. Aberdeen Wealth Management LLC now owns 20,651 shares of the company's stock worth $1,877,000 after purchasing an additional 125 shares during the last quarter. Town & Country Bank & Trust CO dba First Bankers Trust CO boosted its stake in shares of Colgate-Palmolive by 4.0% during the 1st quarter. Town & Country Bank & Trust CO dba First Bankers Trust CO now owns 3,388 shares of the company's stock worth $317,000 after purchasing an additional 130 shares during the last quarter. Finally, Continuum Advisory LLC boosted its stake in shares of Colgate-Palmolive by 17.2% during the 4th quarter. Continuum Advisory LLC now owns 893 shares of the company's stock worth $81,000 after purchasing an additional 131 shares during the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Trading Down 0.6%

CL opened at $87.93 on Monday. The firm has a market capitalization of $71.26 billion, a P/E ratio of 24.84, a P/E/G ratio of 4.53 and a beta of 0.37. The firm's 50 day moving average is $90.24 and its 200-day moving average is $90.39. Colgate-Palmolive Company has a 52-week low of $85.32 and a 52-week high of $109.30. The company has a quick ratio of 0.54, a current ratio of 0.85 and a debt-to-equity ratio of 8.96.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings data on Friday, April 25th. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.86 by $0.05. The company had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.92 billion. Colgate-Palmolive had a net margin of 14.52% and a return on equity of 461.04%. The business's quarterly revenue was down 3.0% on a year-over-year basis. During the same quarter last year, the firm posted $0.86 earnings per share. Analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 15th. Stockholders of record on Friday, July 18th will be paid a dividend of $0.52 per share. The ex-dividend date of this dividend is Friday, July 18th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.37%. Colgate-Palmolive's dividend payout ratio is currently 58.76%.

Analyst Ratings Changes

Several research analysts have recently weighed in on the stock. Citigroup increased their price objective on shares of Colgate-Palmolive from $103.00 to $108.00 and gave the stock a "buy" rating in a report on Monday, April 28th. JPMorgan Chase & Co. cut their price objective on shares of Colgate-Palmolive from $103.00 to $99.00 and set an "overweight" rating on the stock in a report on Friday. UBS Group cut their price objective on shares of Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating on the stock in a report on Thursday, July 17th. Wells Fargo & Company increased their price objective on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the stock an "underweight" rating in a report on Wednesday, April 2nd. Finally, Wall Street Zen lowered shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a report on Wednesday, May 7th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and seven have given a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $100.77.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.